Low rates of clinical restenosis with the new flexible stainless steel tube intracoronary stent: the R Stent. A six-month safety and feasibility study — A.H.M. Knook (2000) | RDL Network
Low rates of clinical restenosis with the new flexible stainless steel tube intracoronary stent: the R Stent. A six-month safety and feasibility study
International Journal of Cardiovascular Interventions 3(2): 91-95
Article 2000 English
Authors
AK
A.H.M. Knook
AW
Alexander J. Wardeh
BR
Benno J. Rensing
Abstract
1 min read
BACKGROUND: Coronary stents have been used with increasing frequency and in increasingly complex coronary lesions for the treatment of symptomatic coronary artery disease. A new stainless steel coronary stent, the R Stent, has been designed to provide maximum flexibility for tracking and high radial strength post-deployment. AIMS: To assess the safety and feasibility of the R Stent in patients with coronary artery disease. Specific objectives were to assess the R Stent's deployment success, angiographic and procedural success (< 20% residual stenosis and TIMI 3 flow), safety (absence of complications), 30-day and six-month clinical follow-up. METHODS: Between April 1998 and January 1999, stent deployment was attempted in 36 lesions in 30 patients with stable (43%) or unstable (57%) angina pectoris and 29/36 of the lesions were anatomically complex. Treated lesions were in the LAD (n = 15), RCA (n = 13) or LCX (n = 8). RESULTS: Stent deployment was achieved in 97% with one crossing failure in a patient with a long, calcified, proximal LAD lesion. After the procedure, patients were scheduled for one- and six-month clinical follow-up. One patient experienced a non-Q-wave myocardial infarction in hospital. At one month, there were no additional complications. Only one patient experienced recurrence of angina (CCS class 2) within the 30 days. At six-month follow-up, one sudden death had occurred. Three (10%) patients had anginal complaints, one of them received target lesion repeat PTCA. All other patients (87%) were event- and angina-free. CONCLUSION: This first clinical experience with the R Stent shows acceptable feasibility and safety with good long-term clinical results.
Michael J.B. Kutryk, Alexander J. Wardeh, A.H.M. Knook, David P. Foley, Willem J. van der Giessen, J Hamburger, Marcel van den Brand, Pim J. de Feyter, Gary J. Becker, Patrick W. Serruys
International Journal of Cardiovascular Interventions
Peter den Heijer, Benno J. Rensing, David P. Foley, Arjan A. van den Bos, H.M.A. Corbeij, M A Q. van Ufford, Johannes A M te Riele, Paul C H Rooset, Patrick W. Serruys
Michael Magro, Joanna J. Wykrzykowska, Patrick W. Serruys, Cihan Şimşek, Sjoerd T. Nauta, Maciej Lesiak, Katarzyna Stanisławska, Yoshinobu Onuma, Evelyn Regar, Ron T. van Domburg, Stefan Grajek, Robert‐Jan van Geuns
Wolfgang Rutsch, Ferdinand Kiemeneij, Antonio Colombo, Carlos Macaya, Jean-Léon Guermonprez, Lars Grip, J Hamburger, Victor A. Umans, Mervyn S. Gotsman, Yaron Almagor, Marie‐Claude Morice, Eulogio Garcı́a, Bernard Chevalier, Raimund Erbel, Michael Cobaugh, Marie-Angèle Morel, Patrick W. Serruys
International Journal of Cardiovascular Interventions
Pascal Vranckx, Patrick W. Serruys, Sanjay Gambhir, Edson Canuto Sousa, Alexandre Abizaid, Pedro A. Lemos, Expedito E. Ribeiro, S. Dani, Jamshed Dalal, Vivek K. Mehan, Arup Dhar, Ashok Dutta, K N Reddy, R.K. Prem Chand, Alireza Ray, Janette Symons
Discussion(0)
No comments yet. Be the first to comment.